PreciVax Therapeutics is the first company in HK developing innovative vaccines for drug resistant bacterial infections. Our first product is a vaccine for Methicillin-resistant Staphylococcus aureus (MRSA).
Company Details
- Address
- Hong Kong, Hong Kong,hong Kong 000000,hong Kong
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Hong Kong, Hong Kong
Precivax Therapeutics Questions
Precivax Therapeutics's LinkedIn profile is https://hk.linkedin.com/company/precivax
Precivax Therapeutics's industry is
Biotechnology Research
Precivax Therapeutics's top competitors are
Renewvax Ltd,
Baxerna,
Althost Consortium,
Bactivax Itn,
Delonix Bioworks,
Abvacc,
Syntiron,
Vaxeng,
Hafion, Inc.,
Id-Antigens.
Precivax Therapeutics's categories are Biotechnology Research
